Vident Advisory’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.58M Buy
6,039
+1,807
+43% +$900K 0.03% 448
2025
Q4
$2.06M Sell
4,232
-1,276
-23% -$594K 0.02% 573
2025
Q3
$2.31M Sell
5,508
-9,071
-62% -$3.05M 0.02% 526
2025
Q2
$4.19M Sell
14,579
-3,162
-18% -$945K 0.05% 316
2025
Q1
$5.47M Buy
17,741
+5,520
+45% +$1.89M 0.08% 218
2024
Q4
$4.31M Buy
12,221
+1,596
+15% +$587K 0.08% 233
2024
Q3
$3.81M Buy
10,625
+3,724
+54% +$1.26M 0.1% 215
2024
Q2
$2.2M Buy
6,901
+1,806
+35% +$478K 0.06% 335
2024
Q1
$1.17M Buy
5,095
+573
+13% +$129K 0.02% 531
2023
Q4
$994K Buy
4,522
+1,818
+67% +$419K 0.03% 560
2023
Q3
$611K Buy
+2,704
New +$623K 0.02% 644

Other funds holding UTHR